A detailed history of Westside Investment Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Westside Investment Management, Inc. holds 17,399 shares of ABBV stock, worth $2.98 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
17,399
Previous 17,889 2.74%
Holding current value
$2.98 Million
Previous $2.77 Billion 14.22%
% of portfolio
0.76%
Previous 0.71%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$159.82 - $182.1 $78,311 - $89,229
-490 Reduced 2.74%
17,399 $3.17 Billion
Q4 2023

Jan 12, 2024

SELL
$137.6 - $154.97 $19,264 - $21,695
-140 Reduced 0.78%
17,889 $2.77 Billion
Q2 2023

Jul 14, 2023

SELL
$132.51 - $164.9 $13,251 - $16,490
-100 Reduced 0.55%
18,029 $2.43 Billion
Q1 2023

May 17, 2023

SELL
$144.61 - $166.54 $44,829 - $51,627
-310 Reduced 1.68%
18,129 $2.89 Billion
Q4 2022

Jan 31, 2023

SELL
$138.31 - $165.87 $11,064 - $13,269
-80 Reduced 0.43%
18,439 $283 Million
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $17,447 - $20,010
-130 Reduced 0.7%
18,519 $234 Million
Q2 2022

Jul 15, 2022

SELL
$137.62 - $174.96 $9,633 - $12,247
-70 Reduced 0.37%
18,649 $2.86 Million
Q1 2022

Apr 25, 2022

SELL
$131.98 - $163.75 $444,772 - $551,837
-3,370 Reduced 15.26%
18,719 $3.03 Million
Q4 2021

Feb 15, 2022

SELL
$107.43 - $135.93 $29,006 - $36,701
-270 Reduced 1.21%
22,089 $2.99 Million
Q3 2021

Oct 27, 2021

BUY
$106.4 - $120.78 $148,321 - $168,367
1,394 Added 6.65%
22,359 $2.41 Million
Q2 2021

Jul 28, 2021

SELL
$105.21 - $117.21 $10,521 - $11,721
-100 Reduced 0.47%
20,965 $2.36 Million
Q1 2021

Apr 14, 2021

BUY
$102.3 - $112.62 $234,778 - $258,462
2,295 Added 12.23%
21,065 $2.28 Million
Q4 2020

Jan 15, 2021

SELL
$80.49 - $108.67 $5,070 - $6,846
-63 Reduced 0.33%
18,770 $2.01 Million
Q3 2020

Oct 14, 2020

BUY
$85.91 - $100.83 $408,158 - $479,043
4,751 Added 33.74%
18,833 $1.65 Million
Q2 2020

Jul 21, 2020

SELL
$73.37 - $98.18 $122,234 - $163,567
-1,666 Reduced 10.58%
14,082 $1.38 Million
Q1 2020

Apr 16, 2020

BUY
$64.5 - $97.79 $744,459 - $1.13 Million
11,542 Added 274.42%
15,748 $1.2 Million
Q2 2019

Jul 24, 2019

SELL
$65.7 - $83.98 $5,058 - $6,466
-77 Reduced 1.8%
4,206 $305,000
Q4 2018

Feb 05, 2019

SELL
$77.85 - $96.01 $10,587 - $13,057
-136 Reduced 3.08%
4,283 $394,000
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $4,578 - $5,417
51 Added 1.17%
4,419 $0
Q1 2018

Apr 16, 2018

SELL
$92.01 - $123.21 $58,794 - $78,731
-639 Reduced 12.76%
4,368 $0
Q4 2017

Feb 15, 2018

SELL
$89.56 - $98.21 $102,546 - $112,450
-1,145 Reduced 18.61%
5,007 $0
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $18,859 - $24,089
270 Added 4.59%
6,152 $0
Q2 2017

Aug 15, 2017

BUY
N/A
5,882
5,882 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Westside Investment Management, Inc. Portfolio

Follow Westside Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.